Breaking out: Improving economy will raise demand for name-brand drugs, boosting revenue

Over the five years to 2018, the Cold Sore Medication Manufacturing industry has experienced stable, if slow, growth. Falling unemployment, rising per capita disposable income and the expansion of healthcare coverage under the Patient Protection and Affordable Care Act (PPACA) have increased the number of individuals able to afford industry products, boosting demand in recent years. Moreover, the industry has benefited from an increase in the median age of the population. Over the next five years, industry revenue is projected to rise...purchase to read more.

Industry Statistics & Market Size
Revenue
$312m
Annual Growth 13-18
2.4%
Forecast Growth 18-23
Profit
Employment
985
Businesses
29

Industry Threats & Opportunities

  • An increase in the popularity of generic cold sore medications has reduced industry revenue
  • Industry revenue increased as private and public insurance coverage expanded
  • As the economy gains steam, consumers will increasingly switch from generic to premium brands
  • Industry Report - Industry SWOT Analysis Chapter

    The Cold Sore Medication Manufacturing industry is in the mature stage of its life cycle. Indicators of this phase include high public acceptance of industry products and a stable number of manufacturers. Furthermore, industry value added, which measures the industry's contribution to the overall economy, is forecast to rise an annualized 1.8% over the 10 years to 2023. Although this growth rate lags slightly behind annualized US GDP growth of 2.1% during the same 10-year period, the industry is largely maintaining its share of the overall economy.The Cold Sore Medication Manufacturing industry benefits from its high degree of public acceptance and use. Mil...purchase to read more.

    Additional Insights for the Cold Sore Medication Manufacturing Industry

    IBISWorld identifies 250 Key Success Factors for a business.The most important for the Cold Sore Medication Manufacturing Industry are

  • Undertaking pharmaceutical and medicine R&D
  • Establishment of brand names
  • Degree of globalization in the firm
  • IBISWorld analysts also discuss how external factors such as Per capita disposable income and Median age of population in the Cold Sore Medication Manufacturing industry impact industry performance..

    shopping_cartPURCHASE OPTIONS

    What's in this report

    Table of Contents

    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Executive Summary
    Key External Drivers
  • Per capita disposable income
  • Median age of population
  • Research and development expenditure
  • Total health expenditure
  • Trade-weighted index

  • Current Performance
  • Demographic factors
  • Economic trends
  • Competition at home and abroad
  • Chart: Revenue Growth

  • Industry Outlook
  • Demographics and economics
  • Competition and expansion
  • Table: Cold Sore Medication Manufacturing Industry Revenue Outlook

  • Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - Cold Sore Medication Manufacturing Industry Lifecycle vs The Economy

  • Supply Chains
    Key Buying Industries
  • Drug, Cosmetic & Toiletry Wholesaling
  • Supermarkets & Grocery Stores
  • Pharmacies & Drug Stores
  • Health Stores
  • Hospitals

  • Key Selling Industries
  • Biotechnology
  • Chemical Product Manufacturing
  • Medical Device Manufacturing
  • Medical Instrument & Supply Manufacturing
  • Soap & Cleaning Compound Manufacturing

  • Products & Services
  • Oral prescription medications
  • OTC medications and generics
  • Topical prescription medications
  • Chart: Cold Sore Medication Manufacturing Industry Products and Services Segmentation

  • Demand Determinants
  • Insurance a key determinant
  • Direct-to-consumer marketing
  • General economic conditions

  • Major Markets
  • Drug stores
  • Big box/discount stores
  • Grocery stores
  • Exports
  • Specialty health stores
  • Chart: Major Market Segmentation for the Cold Sore Medication Manufacturing Industry

  • International Trade
    Business Locations
    Chart: Business Locations by State
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
    ProfitWagesResearch and developmentPurchasesMarketingOther expenses
  • Chart: Cost Structure Benchmarking – Sector vs Cold Sore Medication Manufacturing

  • Basis of Competition
  • Exclusivity times
  • Marketing ability and promotional spending

  • Barriers to Entry
  • Table: Barrier to Entry Checklist for the Cold Sore Medication Manufacturing Industry

  • Industry Globalization
    GlaxoSmithKline PLC, Novartis AG,
  • Table: GlaxoSmithKline PLC - financial performance
  • Table: Novartis AG - financial performance

  • Capital Intensity
  • Chart: Level of Capital Intensity for the Cold Sore Medication Manufacturing Industry
  • Chart: Tools of the Trade: Growth Strategies for Success

  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth

  • Regulation & Policy
    Industry Assistance
    Table: Industry Data for the Cold Sore Medication Manufacturing Industry
    Includes:
  • Industry Revenue (2009-2023)
  • Industry Gross Product (2009-2023)
  • Establishments (2009-2023)
  • Businesses (2009-2023)
  • Employment (2009-2023)
  • Exports (2009-2023)
  • Imports (2009-2023)
  • Wages (2009-2023)
  • Healthcare expenditure (2009-2023)

  • Table: Annual Percentage Change for Key Industry Data
    Table: Key Ratios for Industry Key Data
    Generic
  • Nonproprietary; denoting a drug name not protected by a trademark, usually descriptive of the drug's chemical structure.
  • Otc
  • Over the counter; medications not requiring a prescription.
  • Private Label Brands
  • Products developed and marketed by a retailer and only available for sale by that retailer. Also called store brands.
  • Topical
  • Designed for or involving application to or action on the surface of a part of the body.
  • What Our Customers Say

    Why buy this report?

    IBISWorld’s industry research report on Cold Sore Medication Manufacturing contains five-year forecasts and data analysis that can help you identify and mitigate risks in potential new markets. Position yourself as an expert with internal stakeholders by using our comprehensive industry research to inform your reports, proposals and presentations. Our business information will save you money by helping you make better decisions, faster.

    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on Cold Sore Medication Manufacturing:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding of industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The Cold Sore Medication Manufacturing market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on Cold Sore Medication Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    Contact Us

    Want to speak to a representative? Call us.

    clear